Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure
Giorgino, Francesco, Caruso, Irene, Moellmann, Julia, Lehrke, MichaelJournal:
Metabolism
DOI:
10.1016/j.metabol.2019.154045
Date:
December, 2019
Fichier:
PDF, 791 KB
2019